Literature DB >> 29198134

If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.

Laurie Sylla1, David Evans2,3, Jeff Taylor4,5, Adam Gilbertson6, David Palm5, Judith D Auerbach7, Karine Dubé8.   

Abstract

Global interest and investment in the search for an HIV cure has increased. Research has focused on what experts refer to as a sterilizing or eradicating cure, where HIV is eliminated from the body, and on what is often called a functional cure, where HIV remains, kept durably suppressed in the absence of antiretroviral treatment and therapy (ART). Many believe that a functional cure is likely to be found first. HIV cure studies will require active participation by people living with HIV (PLWHIV). Their desires and perceptions will be important to effectively recruit study participants and for the uptake of any future strategy that demonstrates safety and efficacy. The perspectives of PLWHIV are essential to advancing HIV cure research, and they should be taken into consideration as biomedical research advances. We conducted 10 focus groups in four U.S. cities, eliciting perspectives of PLWHIV on HIV cure and cure research. Most participants conceived of a cure as eradicating, and felt favorably toward it. In addition to the physical benefits of a potential cure, participants valued the possible de-stigmatization related to no longer living with HIV, liberation from concerns about transmitting HIV, and freedom from the burden of daily medication. Many participants did not regard a functional cure as an improvement over controlling HIV through ART, were distrustful about viral rebound potential, and noted concerns about medical complications and accompanying psychological distress. Some felt that the risks of HIV cure research were not worth taking. Many were skeptical about science's ability to eliminate HIV from the body.

Entities:  

Keywords:  HIV cure; HIV cure research; PLWHIV; community perceptions; cure; focus groups; people living with HIV

Mesh:

Substances:

Year:  2018        PMID: 29198134      PMCID: PMC5771509          DOI: 10.1089/AID.2017.0178

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  27 in total

Review 1.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

2.  The ethics of HIV "cure" research: what can we learn from consent forms?

Authors:  Gail E Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

Review 3.  Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?

Authors:  Peter A Newman; Naihua Duan; Ellen T Rudy; Peter A Anton
Journal:  AIDS Patient Care STDS       Date:  2004-12       Impact factor: 5.078

Review 4.  Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.

Authors:  Edward J Mills; Dugald Seely; Beth Rachlis; Lauren Griffith; Ping Wu; Kumanan Wilson; Peter Ellis; James R Wright
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

5.  "Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown.

Authors:  Peter A Newman; Carmen Logie; Llana James; Tamicka Charles; John Maxwell; Khaled Salam; Michael Woodford
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

6.  HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives.

Authors:  Keymanthri Moodley; Ciara Staunton; Malcolm de Roubaix; Mark Cotton
Journal:  AIDS Care       Date:  2015-11-13

7.  A global survey of HIV-positive people's attitudes towards cure research.

Authors:  R Simmons; M Kall; S Collins; G Cairns; S Taylor; M Nelson; S Fidler; K Porter; J Fox
Journal:  HIV Med       Date:  2016-05-11       Impact factor: 3.180

8.  Experiences of coercion to sterilize and forced sterilization among women living with HIV in Latin America.

Authors:  Tamil Kendall; Claire Albert
Journal:  J Int AIDS Soc       Date:  2015-03-24       Impact factor: 5.396

9.  'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.

Authors:  Karine Dubé; Jeff Taylor; Laurie Sylla; David Evans; Lynda Dee; Alasdair Burton; Loreen Willenberg; Stuart Rennie; Asheley Skinner; Joseph D Tucker; Bryan J Weiner; Sandra B Greene
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

10.  A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?

Authors:  Michael M Lederman; Paula M Cannon; Judith S Currier; Carl H June; Hans Peter Kiem; Daniel R Kuritzkes; Sharon R Lewin; David M Margolis; Joseph M McCune; John W Mellors; Timothy W Schacker; Rafick P Sekaly; Pablo Tebas; Bruce D Walker; Daniel C Douek
Journal:  Pathog Immun       Date:  2016
View more
  26 in total

1.  Human Immunodeficiency Virus Transmission Risk in Analytical Treatment Interruption Studies: Relational Factors and Moral Responsibility.

Authors:  Liza Dawson
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

2.  Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366.

Authors:  Karine Dubé; Lara Hosey; Kate Starr; Liz Barr; David Evans; Erin Hoffman; Danielle M Campbell; Jane Simoni; Jeremy Sugarman; John Sauceda; Brandon Brown; Karen L Diepstra; Catherine Godfrey; Daniel R Kuritzkes; David A Wohl; Rajesh Gandhi; Eileen Scully
Journal:  AIDS Res Hum Retroviruses       Date:  2020-04       Impact factor: 2.205

3.  Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.

Authors:  Karine Dubé; Danielle M Campbell; Kelly E Perry; John T Kanazawa; Parya Saberi; John A Sauceda; Tonia Poteat; David Evans
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-14       Impact factor: 2.205

4.  Addressing Ethical Challenges in US-Based HIV Phylogenetic Research.

Authors:  Liza Dawson; Nanette Benbow; Faith E Fletcher; Seble Kassaye; Amy Killelea; Stephen R Latham; Lisa M Lee; Thomas Leitner; Susan J Little; Sanjay R Mehta; Omar Martinez; Brian Minalga; Art Poon; Stuart Rennie; Jeremy Sugarman; Patricia Sweeney; Lucia V Torian; Joel O Wertheim
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

5.  The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.

Authors:  Karine Dubé; Shadi Eskaf; David Evans; John Sauceda; Parya Saberi; Brandon Brown; Dawn Averitt; Krista Martel; Maria Meija; Danielle Campbell; Liz Barr; John Kanazawa; Kelly Perry; Hursch Patel; Stuart Luter; Tonia Poteat; Judith D Auerbach; David A Wohl
Journal:  AIDS Res Hum Retroviruses       Date:  2019-12-04       Impact factor: 2.205

6.  The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.

Authors:  Luisa Mori; Katharine Jenike; Yang-Hui Jimmy Yeh; Benoît Lacombe; Chuan Li; Adam Getzler; Sonia Mediouni; Michael Cameron; Matthew Pipkin; Ya-Chi Ho; Bertha Cecilia Ramirez; Susana Valente
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

7.  Acceptability of Cell and Gene Therapy for Curing HIV Infection Among People Living with HIV in the Northwestern United States: A Qualitative Study.

Authors:  Karine Dubé; Jane Simoni; Michael Louella; Laurie Sylla; Zahra H Mohamed; Hursch Patel; Stuart Luter; Ann C Collier
Journal:  AIDS Res Hum Retroviruses       Date:  2019-05-21       Impact factor: 2.205

8.  "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.

Authors:  Ilona Fridman; Peter A Ubel; Jennifer Blumenthal-Barby; Cameron V England; Judith S Currier; Nir Eyal; Kenneth A Freedberg; Scott D Halpern; Colleen F Kelley; Daniel R Kuritzkes; Catherine N Le; Jeffrey L Lennox; Kathryn I Pollak; Brian J Zikmund-Fisher; Karen A Scherr
Journal:  AIDS Behav       Date:  2020-07

9.  Assessing potential cures: are there distinctive elements of value beyond health gain?

Authors:  Saskia Hendriks; Steven D Pearson
Journal:  J Comp Eff Res       Date:  2021-03-05       Impact factor: 1.744

10.  HIV Cure Research: Risks Patients Expressed Willingness to Accept.

Authors:  Allison Kratka; Peter A Ubel; Karen Scherr; Benjamin Murray; Nir Eyal; Christine Kirby; Madelaine N Katz; Lisa Holtzman; Kathryn Pollak; Kenneth Freedburg; Jennifer Blumenthal-Barby
Journal:  Ethics Hum Res       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.